PTC Therapeutics Inc (NASDAQ:PTCT)

47.50
Delayed Data
As of Apr 09
 -0.76 / -1.57%
Today’s Change
43.65
Today|||52-Week Range
70.82
-22.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues36.8M82.7M194.4M264.7M
 
 
 
 
 
Cost of Goods Sold----2.3M9.5M
 
 
 
Depreciation And Amortization2.9M3.3M17.7M26.1M
 
 
 
 
 
 
Operating ExpensesGross Income----174.4M229.2M
 
 
 
General Expenses201.0M209.0M238.7M323.8M
 
 
 
 
 
Research And Development121.8M117.6M117.5M172.0M
 
 
 
 
 
Total Operating Expenses203.9M212.3M258.7M359.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-167.1M-129.6M-64.3M-94.6M
 
 
 
 
 
Extraordinary Credit140.0K47.0K0.000.00
 
 
 
Extraordinary Charge0.00-2.5M0.00-21.0M
 
 
 
Interest Expense On Debt2.4M8.3M12.1M12.6M
 
 
 
 
 
Other Expenses-605.0K-1.3M-1.3M129.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-170.0M-141.5M-77.7M-128.1M
 
 
 
 
 
Income Taxes-485.0K-569.0K-1.3M-29.0K
 
 
 
 
 
Net Income-170.4M-142.1M-79.0M-128.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.6M34.0M39.2M46.6M
 
 
 
 
 
Shares To Calculate EPS Diluted33.6M34.0M39.2M46.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.07-$4.17-$2.02-$2.75
 
 
 
 
 
EPS Diluted-$5.07-$4.17-$2.02-$2.75